3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
CNS
7
Gastrointestinal
4
Tumor-Agnostic
3
Dermatologic
2
Breast
2
Sarcoma
1
NET
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Conditions
Pituitary Neoplasms
4
Thyroid Cancer, Papillary
2
Neuroendocrine Tumors
2
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Pituitary Diseases
1
Pheochromocytoma
1
Neoplasm Metastasis
1
Multiple Endocrine Neoplasia Type 1
1
Lymphatic Metastasis
1
Insulinoma
1
Infertility
1
Extranodal Extension
1
Esthesioneuroblastoma, Olfactory
1
Adrenal Gland Neoplasms
1
Adenocarcinoma, Follicular
1
Acromegaly
1
Interventions
Doxorubicin
4
Sunitinib
3
Radiosurgery
3
Everolimus
3
pembrolizumab
2
exemestane
2
Tamoxifen
2
Specimen Handling
2
Octreotide
2
Magnetic Resonance Spectroscopy
2
Fulvestrant
2
Filgrastim
2
Biopsy
2
Bevacizumab
2
3-Iodobenzylguanidine
2
tislelizumab
1
surufatinib
1
romidepsin
1
regorafenib
1
penpulimab
1
pasireotide
1
mercaptoundecahydrododecaborate
1
lutetium Lu 177 dotatate
1
lanreotide
1
ganitumab
1
folfirinox
1
fludarabine phosphate
1
epothilone B
1
entrectinib
1
dostarlimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Surgical Procedures, Operative
×
Endocrine
×
Clear all
NCT04066322
2019-09-24
RMPanNET
Fudan University
Unknown
180 enrolled